← Open Payments lookup

SURYAMOL CHACKO: Open Payments

NPI 1053793927 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,038 in 22 payments from 15 companies in 2025. Trend: 2023 $2,487 · 2024 $1,680 · 2025 $2,038

Food & beverage: $2,038
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.2$247
Phathom Pharmaceuticals, Inc.2$233
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$173
Insmed, Inc.2$170
VERTEX PHARMACEUTICALS INCORPORATED2$167
Neurocrine BioSciences, Inc.1$140
ARS Pharmaceuticals Operations, Inc.1$125
Madrigal Pharmaceuticals2$125
Hologic Sales and Service, LLC1$119
ABBVIE INC.1$111

Products named: VOQUEZNA, XIFAXAN, Arikayce, INGREZZA, NEFFY, REZDIFFRA, APTIMA, LINZESS.

Industry payments across MD — which companies pay providers there.